This article originally posted 03 May, 2002 and appeared in
Retinopathy
As we examine characteristics of diabetic retinopathy it shows to have very similar pathologies to that of both nephropathy and neuropathy. Its development seems to be slightly more common in Type II than Type I diabetes, especially at or shortly after the time of the actual diabetic diagnosis. Regardless the type of diabetes, the usual percentage of incidents of occurrences of retinopathy will begin gradually then increase dramatically as the years of disease duration approaches twenty.
Advertisement
One of
the first signs of changes taking place within the eye is the development of
microaneurysms in retinal capillaries. Vision does not seem to be affected at
this point so this event will usually go unnoticed by the person involved, but
an opthamologist should be able to detect it. Then the next progression of diabetic
retinopathy is excessive vascular permeability causing leakage of the retinal
capillaries. Now, at this stage at least some impairment of vision becomes more
likely to occur.
There is evidence that a period of capillary vascular occlusion takes place
shortly before the next development which is the vasoproliferation stage commonly
known as proliferative diabetic retinopathy (PDR). PDR is responsible for the
more severe types of visual loss associated with this complication. PDR is the
growth of new unstable vessels in the retina that have an increased likeliness
of bleeding which may lead to fibrosis, retinal detachment and blindness. The
first risk factor to examine is hyperglycemia. Hyperglycemia seems to play the
most integral role in the progression of this complication which is vascular
in nature.
The elevated serum levels of glucose is responsible for the increase in oxidant
stress, production of sorbitol and thickening of basement membrane within the
lens in the eye. Oxidant stress causes damage through the production of free
radicals in ocular tissue and also is associated with retinal detachment. The
accumulation of sorbitol, through the polyol pathway, will cause an osmotic
imbalance that will lead to impaired cell function within the eye and the possible
development of cataracts. The thickening of capillary basement membranes is
likely the end result of incurred vascular damage caused by either one or a
combination of the oxidant stress and sorbitol accumulation.
Now, that we have covered some of the more plausible causes of diabetic retinopathy,
let us look at what can be done to prevent or reverse this condition. As with
development of other diabetic complications, the need to correct or improve
blood sugar control is the first place to start.
There are a number of studies, especially those from the Diabetes Control and
Complication Trial, that confirm good blood glucose control will delay or even
prevent diabetic complications.
The next area that should addressed, is that of oxidant stress. It has been
well concluded that patients with diabetes suffer from increased oxidant stress
as compared to non-diabetics. Also, patients with diabetes have lower serum
levels of antioxidants including vitamin C, E and beta carotene.
Oral supplementation of antioxidants have shown be effective in treating the
conditions that precipitate retinopathy.[i] [ii] Vitamin E has been proven to
normalize retinal blood flow that is usually decreased in patients with diabetes.
Another study showed excellent results in the treatment of retinopathy with
vitamin B6.[iii] Like other diabetic complications that have elevated sorbitol
levels, treatment with inositol shows some benefit. The use of zinc supplementation
might offer a protective action to the retina as demonstrated in this study
of Type I patients with diabetes.[iv]
There are several herbs that display properties that make them particularly
effective in directly treating diabetic retinopathy. One is an extract of the
leaf of the bilberry plant. It has the ability to decrease the permeability
and tendency to hemorrhage in the capillaries within the eye and may offer some
systemic benefit as well.[v] [vi] Ginkgo biloba extract has been well known
for its value in treating conditions in the circulatory system. This trial of
Ginkgo biloba showed significant improvement in the condition of diabetic retinopathy
in its participates.[vii]
Since the development of retinopathy or any complications for that matter are
multi-factorial, the most complete approach to treatment should be the utilization
of all of the known effective therapies available.
Dr. Brian P. Jakes, Jr., N.D., C.N.C. is a Board Certified Doctor of Naturopathy
as well as a Certified Nutritional Consultant. In his practice, in Mandeville,
LA, Dr. Jakes works with physicians to treat a large number of diabetes patients.
[i] Jacques PF, Taylor A, Hankinson SE, Willett WC. Long term vitamin C supplement
use and prevalence of early age related lens opacities. Am J Clin Nutr 1997
Oct;66(4):911-6.
[ii] Grattagliano I, Vendemiale G, Boscia F, Micelli-Ferrari T. Oxidative retinal
products and ocular damages in diabetic patients. Free Radic Biol Med 1998 Aug;25(3):369-72.
[iii] Ellis JM, Folkers K, Minadeo M, VanBuskirk R, Xia LJ, Tamagawa H. A deficiency
of vitamin B6 is a plausible molecular basis of the retinopathy of patients
with diabetes mellitus. Biochem Biophys Res Commun 1991 Aug 30;179(1):615-9.
[iv] Faure P, Benhamou PY, Perard A, Halimi S, Roussel AM. Lipid peroxidation
in insulin dependent diabetic patients with early retina degenerative lesions:
effects of an oral zinc supplementation. Eur J Clin Nutr 1995 Apr;49(4):282-8.
[v] Scharrer A, Ober M. Anthocyanosides in the treatment of retinopathies.
Klin Monatsbl Augenheilkd
1981 May;178(5):386-9.
[vi] Boniface R, Robert AM. Effect of anthocyanins on human connective tissue
metabolism in the human.
Klin Monatsbl Augenheilkd 1996 Dec;209(6):368-72.
[vii] Lanthony P, Cosson JP. The course of color vision in early diabetic retinopathy
treated with Ginkgo biloba extract. J FR Ophtalmol 1988;11(10):671-4.
DISCLAIMER: The content of this Website is independent of the views of our advertisers and sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.
Copyright @ 1999-2012 Diabetes In Control, Inc.. All rights reserved.